Cantitate/Preț
Produs
Total produse
Vezi coșul
Gene and Cellular Immunotherapy for Cancer de Armin Ghobadi

Gene and Cellular Immunotherapy for Cancer: Cancer Drug Discovery and Development

Editat de Armin Ghobadi, John F. DiPersio
en Limba Engleză Paperback – 21 dec 2022
Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more.
 
Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by a diverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 107708 lei  43-57 zile
  Springer International Publishing – 21 dec 2022 107708 lei  43-57 zile
Hardback (1) 108605 lei  43-57 zile
  Springer International Publishing – 20 dec 2021 108605 lei  43-57 zile

Din seria Cancer Drug Discovery and Development

  • 5% CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
    Preț: 144506 lei
  • 5% Developments in T Cell Based Cancer Immunotherapies
    Preț: 108589 lei
  • 5% mTOR Pathway and mTOR Inhibitors in Cancer Therapy
    Preț: 138701 lei
  • 5% Antiangiogenic Agents in Cancer Therapy
    Preț: 137019 lei
  • 5% Tumor Models in Cancer Research
    Preț: 142282 lei
  • 5% Telomeres and Telomerase in Cancer
    Preț: 131674 lei
  • 5% Gene Therapy for Cancer
    Preț: 141031 lei
  • 5% Proteasome Inhibitors in Cancer Therapy
    Preț: 109106 lei
  • 5% Oncogene-Directed Therapies
    Preț: 110341 lei
  • 24% Protein Tyrosine Kinases: From Inhibitors to Useful Drugs
    Preț: 103759 lei
  • 5% Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention
    Preț: 143661 lei
  • 5% Apoptosis, Senescence and Cancer
    Preț: 135078 lei
  • 5% Bioinformatics in Cancer and Cancer Therapy
    Preț: 138878 lei
  • 5% Bone Metastasis
    Preț: 109091 lei
  • 5% Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy
    Preț: 139957 lei
  • 5% Tumor Suppressor Genes in Human Cancer
    Preț: 140079 lei
  • 5% Platinum-Based Drugs in Cancer Therapy
    Preț: 76628 lei
  • 5% Regional Cancer Therapy
    Preț: 140939 lei
  • 5% Checkpoint Controls and Targets in Cancer Therapy
    Preț: 108781 lei
  • 5% Antifolate Drugs in Cancer Therapy
    Preț: 140529 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
    Preț: 136582 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology
    Preț: 143143 lei
  • 5% Farnesyltransferase Inhibitors in Cancer Therapy
    Preț: 108442 lei
  • 5% Supportive Care in Cancer Therapy
    Preț: 98218 lei
  • 5% Nucleic Acid Therapeutics in Cancer
    Preț: 71309 lei
  • 5% Stem Cells and Cancer
    Preț: 133176 lei
  • 5% EGFR Signaling Networks in Cancer Therapy
    Preț: 129740 lei
  • 5% Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics
    Preț: 110180 lei
  • 5% Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
    Preț: 140403 lei
  • 5% Hormone Therapy in Breast and Prostate Cancer
    Preț: 108838 lei
  • 5% Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications
    Preț: 131776 lei
  • 5% The Oncogenomics Handbook
    Preț: 143518 lei
  • 5% Macromolecular Anticancer Therapeutics
    Preț: 190025 lei
  • 5% Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions
    Preț: 138969 lei
  • 5% Cancer Drug Resistance
    Preț: 140976 lei
  • 5% Matrix Metalloproteinase Inhibitors in Cancer Therapy
    Preț: 107799 lei
  • 5% Fluoropyrimidines in Cancer Therapy
    Preț: 108746 lei
  • 5% In Vivo Imaging of Cancer Therapy
    Preț: 99058 lei
  • 5% The Tumor Microenvironment
    Preț: 141387 lei
  • 5% Camptothecins in Cancer Therapy
    Preț: 139992 lei
  • 5% Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
    Preț: 77165 lei
  • 5% Cancer Proteomics: From Bench to Bedside
    Preț: 131172 lei
  • 5% Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
    Preț: 133176 lei
  • 5% COX-2 Blockade in Cancer Prevention and Therapy
    Preț: 109054 lei
  • 5% Cytokines in the Genesis and Treatment of Cancer
    Preț: 141154 lei

Preț: 107708 lei

Preț vechi: 113377 lei
-5% Nou

Puncte Express: 1616
Preț estimativ în valută:
20613€ • 21412$ • 17122£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030878511
ISBN-10: 3030878511
Pagini: 378
Ilustrații: X, 378 p. 29 illus., 28 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.54 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:Cham, Switzerland

Cuprins

The History of Cellular Therapies.- Basics of Immunity.- Biology of CAR T cells.- Cell types used for CAR generation.- Combination therapeutics with CART cell therapy.- Safety switches used for cellular therapies.- Off-the-shelf CAR-T.- Manufacturing of CAR-T Cells: the Assembly Line.- Navigating Regulations in Gene and Cell Immunotherapy  .- Bringing CAR-T to the Clinic.- CAR T-Cell Complications.- Mechanisms of Resistance and Relapse after CAR T cell therapy.- Tumor infiltrating lymphocytes (TIL): from bench to bedside.- T-cell Receptor (TCR) Engineered Cells and Their Transition to Clinic.- Viral Cytotoxic T Lymphocytes (CTLs): from Bench to Bedside.- Biology of NK cells and NK cells in clinic.- Biology and Clinical Evaluation of T/NK Cell Engagers.- Roadmap for Starting an Outpatient Cellular Therapy Program.- Index.

Notă biografică

Armin Ghobadi is an Associate Professor in the Division of Oncology and clinical director of the Center for Gene and Cellular Immunotherapy (CGCI) at Washington University School of Medicine in St. Louis, and a member of the Alvin J. Siteman Cancer Center. He earned his Medical Diploma at Iran University of Medical Sciences and Health Services School of Medicine in Tehran. Ghobadi’s post graduate training has been at the University of Texas Southwestern Medical School in Dallas, TX, the MD Anderson Cancer Center in Houston, TX and Washington University School of Medicine in St. Louis. Currently his research focuses on cellular therapy for hematologic malignancies, hematopoietic stem cell transplantation, and genome sequencing
 
John F. DiPersio is the Deputy Director of Alvin J. Siteman Cancer Center, Samuel J. Goldman Endowed Professor of Oncology, Chief of the Division of Oncology, and director of the Center for Gene and Cellular Immunotherapy (CGCI) at Washington University School of Medicine inSt. Louis. DiPersio earned a BA in Biology at Williams College in Williamstown, MA and a Ph.D./MD in Microbiology at the University of Rochester, Rochester, NY. Currently, his research focuses on hematopoietic stem cell mobilization, murine models of graft-versus host disease and graft-versus leukemia, leukemia genomics and targeted cellular therapies for the treatment of leukemias.

Textul de pe ultima copertă

Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (ALL). These advances have dramatically improved the management of patients with relapsed refractory lymphoma, myeloma and leukemia. Gene and Cellular Immunotherapy for Cancer offers readers a comprehensive review of current cellular and gene-based immunotherapies. Divided into eighteen cohesive chapters, this book provides an in-depth and detailed look into cellular-based immunotherapies including CAR-T, TCR-T, TIL, Viral CTLs, NK cells in addition to T/NK cell engagers, focusing on their historical perspectives, biology, development and manufacturing, toxicities and more.
Edited by two leading experts on gene and cellular immunotherapy, the book will feature chapters written by adiverse collection of recognized and up-and-coming experts and researchers in the field, providing oncologists, immunologists, researchers and clinical and basic science trainees with a bench to bedside view of the latest developments in the field.

Caracteristici

The book is a comprehensive and in-depth overview of the latest developments in gene and cellular immunotherapies The content is divided into six cohesive sections, CAR-T, TCR-T, TIL, Viral CTL, NK Cell, and T/NK Cell Engagers This book will feature chapters written by a collection of recognized and up-and-coming researchers in the field